Related references
Note: Only part of the references are listed.Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia
Brian Parkin et al.
BLOOD (2013)
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML
Anuhar Chaturvedi et al.
BLOOD (2013)
Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
Garrett W. Rhyasen et al.
CANCER CELL (2013)
Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34+ cells from patients with del(5q) myelodysplastic syndrome
Christopher P. Venner et al.
HAEMATOLOGICA (2013)
Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
Tomoya Muto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
Omar Abdel-Wahab et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
C. Craddock et al.
LEUKEMIA (2013)
Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
Wendy W. Pang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
Julie-Aurore Losman et al.
SCIENCE (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Fang Wang et al.
SCIENCE (2013)
Effect of intravenous coadministration of human stroma cell lines on engraftment of long-term repopulating clonal myelodysplastic syndrome cells in immunodeficient mice
X. Li et al.
BLOOD CANCER JOURNAL (2013)
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol et al.
BLOOD (2012)
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
Satomi Tanaka et al.
BLOOD (2012)
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
Laura Barreyro et al.
BLOOD (2012)
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
Britta Will et al.
BLOOD (2012)
H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia
Masahiro Kawahara et al.
CANCER CELL (2012)
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Omar Abdel-Wahab et al.
CANCER CELL (2012)
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch et al.
CELL (2012)
GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia
Neil P. Rodrigues et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Hematopoietic stem cell development requires transient Wnt/β-catenin activity
Cristina Ruiz-Herguido et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients
M. M. Patnaik et al.
LEUKEMIA (2012)
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Masato Sasaki et al.
NATURE (2012)
Dnmt3a is essential for hematopoietic stem cell differentiation
Grant A. Challen et al.
NATURE GENETICS (2012)
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia
Max Jan et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
FLT3 and NPM1 Mutations in Myelodysplastic Syndromes Frequency and Potential Value for Predicting Progression to Acute Myeloid Leukemia
Ashish Bains et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Ex vivo maintenance of hematopoietic stem cells by quiescence induction through Fbxw7α overexpression
Hirono Iriuchishima et al.
BLOOD (2011)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron et al.
CANCER CELL (2011)
Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia
Nicolas Goardon et al.
CANCER CELL (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
Functional Crosstalk between Bmi1 and MLL/Hoxa9 Axis in Establishment of Normal Hematopoietic and Leukemic Stem Cells
Lan-Lan Smith et al.
CELL STEM CELL (2011)
Establishment of a xenograft model of human myelodysplastic syndromes
Yukari Muguruma et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
M. J. Walter et al.
LEUKEMIA (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Growth Factor Independence 1 Protects Hematopoietic Stem Cells Against Apoptosis but Also Prevents the Development of a Myeloproliferative-Like Disease
Cyrus Khandanpour et al.
STEM CELLS (2011)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Maria E. Figueroa et al.
CANCER CELL (2010)
Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells
Keiyo Takubo et al.
CELL STEM CELL (2010)
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis
Felicitas Thol et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q)
A. Pardanani et al.
LEUKEMIA (2010)
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
J. Boultwood et al.
LEUKEMIA (2010)
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
O. Kosmider et al.
LEUKEMIA (2010)
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
A. Pellagatti et al.
LEUKEMIA (2010)
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Myunggon Ko et al.
NATURE (2010)
The Lkb1 metabolic sensor maintains haematopoietic stem cell survival
Sushma Gurumurthy et al.
NATURE (2010)
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Marc H. G. P. Raaijmakers et al.
NATURE (2010)
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells
Boyi Gan et al.
NATURE (2010)
A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome
Jillian L. Barlow et al.
NATURE MEDICINE (2010)
Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype
Daniel T. Starczynowski et al.
NATURE MEDICINE (2010)
Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission
Ramin Tehranchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome
Britta Will et al.
BLOOD (2009)
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
Maria E. Figueroa et al.
BLOOD (2009)
Hematopoietic Stem Cell Expansion Precedes the Generation of Committed Myeloid Leukemia-initiating Cells in C/EBPα Mutant AML
Oxana Bereshchenko et al.
CANCER CELL (2009)
JunB Protects against Myeloid Malignancies by Limiting Hematopoietic Stem Cell Proliferation and Differentiation without Affecting Self-Renewal
Marianne Santaguida et al.
CANCER CELL (2009)
DNA Methyltransferase 1 Is Essential for and Uniquely Regulates Hematopoietic Stem and Progenitor Cells
Jennifer J. Trowbridge et al.
CELL STEM CELL (2009)
Differential gene expression of bone marrow-derived CD34+cells is associated with survival of patients suffering from myelodysplastic syndrome
Wolf C. Prall et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
N. Misaghian et al.
LEUKEMIA (2009)
DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction
Ann-Marie Broeske et al.
NATURE GENETICS (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers
Mayumi Oda et al.
NUCLEIC ACIDS RESEARCH (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse
Paolo Sportoletti et al.
BLOOD (2008)
Malignant transformation initiated by MII-AF9: Gene dosage and critical target cells
Weili Chen et al.
CANCER CELL (2008)
Modeling of C/EBP alpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells
Peggy Kirstetter et al.
CANCER CELL (2008)
Hematopoietic Stem Cell Function and Survival Depend on c-Myc and N-Myc Activity
Elisa Laurenti et al.
CELL STEM CELL (2008)
Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rγnull mice
Lisa J. Giassi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Impaired differentiation and apoptosis of hematopoietic precursors in a mouse model of myelodysplastic syndrome
Chul Won Choi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Benjamin L. Ebert et al.
NATURE (2008)
PML targeting eradicates quiescent leukaemia-initiating cells
Keisuke Ito et al.
NATURE (2008)
The molecular signature of MDS stem cells supports a stem-cell origin of 5q -: myelodysplastic syndromes
Lars Nilsson et al.
BLOOD (2007)
A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia
Ulrike Bacher et al.
HAEMATOLOGICA (2007)
Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells
Ulrich Steidl et al.
NATURE GENETICS (2006)
SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice
Yupo Ma et al.
BLOOD (2006)
Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells
Leopoldo Laricchia-Robbio et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Mechanisms of disease - Cancer stem cells
Craig T. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene expression profiles of CD34+ cells in myelodysplastic syndromes:: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype
Andrea Pellagatti et al.
BLOOD (2006)
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Jiwang Zhang et al.
NATURE (2006)
Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia
YH Kuo et al.
CANCER CELL (2006)
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML):: association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
RGW Verhaak et al.
BLOOD (2005)
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia
YW Lin et al.
BLOOD (2005)
Role of nucleophosmin in embryonic development and tumorigenesis
S Grisendi et al.
NATURE (2005)
IFN-γ negatively modulates self-renewal of repopulating human hemopoietic stem cells
LP Yang et al.
JOURNAL OF IMMUNOLOGY (2005)
To the editor:: Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID-β2-microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells
DMB Kerbauy et al.
BLOOD (2004)
EVI1 induces myelodysplastic syndrome in mice
S Buonamici et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
CHM Jamieson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities
GB Chen et al.
BLOOD (2004)
Leukemogenesis caused by incapacitated GATA-1 function
R Shimizu et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Engraftment of NOD/SCID-β2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome
E Thanopoulou et al.
BLOOD (2004)
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
F Rosenbauer et al.
NATURE GENETICS (2004)
Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers
WH Zeng et al.
BLOOD (2004)
JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells
E Passegué et al.
CELL (2004)
Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γcnull mice model
H Hiramatsu et al.
BLOOD (2003)
NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors
AI Benito et al.
LEUKEMIA RESEARCH (2003)
GLFG and FxFG nucleoporins bind to overlapping sites on importin-β
R Bayliss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow
WK Hofmann et al.
BLOOD (2002)
Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a
L Graf et al.
BLOOD (2002)
Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation
CG de Guzman et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
HOXB4-induced expansion of adult hematopoietic stem cells ex vivo
J Antonchuk et al.
CELL (2002)
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
PM Ayton et al.
ONCOGENE (2001)
Clonality in the myelodysplastic syndromes
J Boultwood et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice
D Louz et al.
LEUKEMIA (2000)